Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-04-16 to 2025-04-16
Current total value of award: $527.46
Description: 4567939489!LAMISIL 1% CRM 30GM 1S